Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching

• Hoofdauteurs: An-Hua Wei (Auteur), Lu Zeng (Auteur), Lu Wang (Auteur), Lin Gui (Auteur), Wen-Ting Zhang (Auteur), Xue-Peng Gong (Auteur), Juan Li (Auteur), Dong Liu (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2023-10-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Nirmatrelvir/ritonavir and azvudine have been approved for the early treatment of COVID-19 in China, however, limited real-world data exists regarding their effectiveness and safety.Methods: We conducted a retrospective cohort study involving the hospitalized COVID-19 patients in China b...